ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,663, issued on Aug. 19, was assigned to Monte Rosa Therapeutics AG (Basel, Switzerland).
"Isoindolinone compounds" was invented by Bernhard Fasching (Basel, Switzerland), Thomas Ryckmans (Basel, Switzerland), Alexander Flohr (Basel, Switzerland), Andreas Ritzen (Basel, Switzerland), Freya Harvey (Basel, Switzerland) and Laura McAllister (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compound or pharmaceutically acceptable salts or stereoisomers thereof of formula I:X1 is linear or branched C1-6 alkyl, C3-8 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, 4-8 membered heterocycloalkyl, wherein X1 is unsubstit...